logo

Michael Saag, MD

Michael Saag, MD

Infectious Disease Birmingham, AL

Professor of Medicine, University Alabama

Office Address

Office Map
  • 619 19th Street South
    UAB Div Infectious Diseases
    Birmingham, AL 35233
    Phone: (205) 934-6600

Dr. Saag's Clinical Specialties & Interests

  • Infectious Disease: General Infectious Disease, HIV/AIDS Medicine

Dr. Saag's Education & Medical Training

  • University of Alabama Medical CenterUniversity of Alabama Medical CenterFellowship, Infectious Disease
  • University of Alabama Medical CenterUniversity of Alabama Medical CenterResidency, Internal Medicine
  • U of Louisville Sch of MedUniversity of Louisville School of MedicineMedical School

Dr. Saag's Certifications & Licensure

  • AL State Medical LicenseAL State Medical License1982 - 2014
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineAmerican Board of Internal MedicineInfectious Disease

Dr. Saag's Awards, Honors, & Recognition

  • The American Society for Clinical InvestigationElected MemberThe American Society for Clinical Investigation, 1997
  • Marquis Whos WhoWhos Who in Medicine and HealthcareMarquis Whos Who

Dr. Saag's Clinical Trials

Dr. Saag's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Integration Of Evidence-Based Alcohol Interventions Into HIV Care
    Integration Of Evidence-Based Alcohol Interventions Into HIV CareNational Institute On Alcohol Abuse And Alcoholism
    2011 - 2011
  • Recent Advances In AIDS And HIV Research
    Recent Advances In AIDS And HIV ResearchNational Institute Of Allergy And Infectious Diseases
    2009 - 2011
  • Administrative Core
    Administrative CoreNational Institute Of Allergy And Infectious Diseases
    2009 - 2011
  • Administrative
    AdministrativeNational Institute Of Allergy And Infectious Diseases
    2008 - 2008
  • ACTG A5229
    ACTG A5229National Center For Research Resources
    2007 - 2007
  • Alabama-Clinical Trials Unit
    Alabama-Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases
    2007 - 2012
  • ACTG A5209 Ezetimibe (ZETIA) In Combination With Statin Therapy For The Treatmen
    ACTG A5209 Ezetimibe (ZETIA) In Combination With Statin Therapy For The TreatmenNational Center For Research Resources
    2006 - 2007
  • A5202, Final Version 10, 05/05/05: Initial Therapy With Different Antiretrovira
    A5202, Final Version 10, 05/05/05: Initial Therapy With Different AntiretroviraNational Center For Research Resources
    2006 - 2007
  • ACTG A5142, V 20
    ACTG A5142, V 20National Center For Research Resources
    2006 - 2006
  • Unsolicited R24 For The Cfar-Network Of Integrated Clinical Sciences, Cnics
    Unsolicited R24 For The Cfar-Network Of Integrated Clinical Sciences, CnicsNational Institute Of Allergy And Infectious Diseases
    2006 - 2011
  • ACTG A5001 (V 30)
    ACTG A5001 (V 30)National Center For Research Resources
    2006 - 2007
  • FRAM 2
    FRAM 2National Center For Research Resources
    2005 - 2007
  • Silcaat V 40
    Silcaat V 40National Center For Research Resources
    2005 - 2007
  • ACTG A5146
    ACTG A5146National Center For Research Resources
    2005 - 2007
  • ACTG A5186
    ACTG A5186National Center For Research Resources
    2005 - 2006
  • ACTG A5178 (Slam-C)
    ACTG A5178 (Slam-C)National Center For Research Resources
    2005 - 2006
  • Amd11070 In Hiv-Positive Subjects (A5210)
    Amd11070 In Hiv-Positive Subjects (A5210)National Center For Research Resources
    2005 - 2007
  • ACTG A5174 Improving Immune Reconstitution With Growth  Hormone In Hiv-Infected
    ACTG A5174 Improving Immune Reconstitution With Growth Hormone In Hiv-InfectedNational Center For Research Resources
    2005 - 2005
  • ACTG A5142, V 20 Comparison Of Lopinavir/Ritonavir PLUS Efavirenz VS Lopinavir/
    ACTG A5142, V 20 Comparison Of Lopinavir/Ritonavir PLUS Efavirenz VS Lopinavir/National Center For Research Resources
    2005 - 2005
  • ACTG A5001 (V 20) Adult AIDS Clinical Trials Group Longitudinal Linked Randomiz
    ACTG A5001 (V 20) Adult AIDS Clinical Trials Group Longitudinal Linked RandomizNational Center For Research Resources
    2005 - 2005
  • ACTG 5095 Comparison Of Three Protease Inhibitor-Sparing Regimens For The Initia
    ACTG 5095 Comparison Of Three Protease Inhibitor-Sparing Regimens For The InitiaNational Center For Research Resources
    2005 - 2005
  • ACTG 5095 Comparison Of Three Protease Inhibitor
    ACTG 5095 Comparison Of Three Protease InhibitorNational Center For Research Resources
    2004 - 2004
  • ACTG A5068
    ACTG A5068National Center For Research Resources
    2004 - 2007
  • ACTG A5181
    ACTG A5181National Center For Research Resources
    2004 - 2005
  • UAB Center For AIDS Research
    UAB Center For AIDS ResearchNational Institute Of Allergy And Infectious Diseases
    2004 - 2011
  • Improving Immune Reconstitution With Growth Hormone
    Improving Immune Reconstitution With Growth HormoneNational Center For Research Resources
    2004 - 2004
  • Adult AIDS Clinical Trials Group Longitudinal Linked
    Adult AIDS Clinical Trials Group Longitudinal LinkedNational Center For Research Resources
    2004 - 2004
  • Comparison Of Lopinavir/Ritonavir PLUS Efavirenz
    Comparison Of Lopinavir/Ritonavir PLUS EfavirenzNational Center For Research Resources
    2004 - 2004
  • Recent Advances In AIDS And HIV Research
    Recent Advances In AIDS And HIV ResearchNational Institute Of Allergy And Infectious Diseases
    2003 - 2007
  • Adult AIDS Clinical Trials Group
    Adult AIDS Clinical Trials GroupNational Institute Of Allergy And Infectious Diseases
    2000 - 2007
  • Viral/Lymphocyte Dynamics  In HIV-1 Infected Patients
    Viral/Lymphocyte Dynamics In HIV-1 Infected PatientsNational Center For Research Resources
    2000 - 2000
  • Core--Clinical
    Core--ClinicalNational Institute Of Allergy And Infectious Diseases
    1998 - 2002
  • T20 Administered To HIV1 Positive Adults
    T20 Administered To HIV1 Positive AdultsNational Center For Research Resources
    1998 - 1999
  • Core--Advanced Technology Laboratories
    Core--Advanced Technology LaboratoriesNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • HIV Disease Research Agenda
    HIV Disease Research AgendaNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • Complications Of HIV Disease Agenda
    Complications Of HIV Disease AgendaNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • Outreach Agenda
    Outreach AgendaNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • Outcomes Committee Agenda
    Outcomes Committee AgendaNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • Pharmacology Agenda
    Pharmacology AgendaNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • Women'S Health Agenda
    Women'S Health AgendaNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • Immunology And Immune Based Therapy Agenda
    Immunology And Immune Based Therapy AgendaNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • Neurology Agenda
    Neurology AgendaNational Institute Of Allergy And Infectious Diseases
    1997 - 1999
  • Antiviral Activity Of GEM 91 In HIV Positive Adults
    Antiviral Activity Of GEM 91 In HIV Positive AdultsNational Center For Research Resources
    1996 - 1996
  • Oral Prednisone In HIV Infection With Unexplained Weight Loss
    Oral Prednisone In HIV Infection With Unexplained Weight LossNational Center For Research Resources
    1996 - 1997
  • AMP B/Flucytosin VS AMP B/Fluconazole In Acute Cryptococcal Meningitis
    AMP B/Flucytosin VS AMP B/Fluconazole In Acute Cryptococcal MeningitisNational Center For Research Resources
    1995 - 1995
  • Itraconazole And Fluconazole In Relapse Of Aids-Related Cryptococcal Meningitis
    Itraconazole And Fluconazole In Relapse Of Aids-Related Cryptococcal MeningitisNational Center For Research Resources
    1995 - 1995
  • AIDS Clinical Trials
    AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases
    1994 - 1995
  • Pharmacokinetics In HIV Infected Adults
    Pharmacokinetics In HIV Infected AdultsNational Center For Research Resources
    1993 - 1993
  • Recombinant Cd4-Immunoglobulin In HIV Infection And Sensitivity To Rcd4-Igg
    Recombinant Cd4-Immunoglobulin In HIV Infection And Sensitivity To Rcd4-IggNational Center For Research Resources
    1993 - 1995
  • Trimetrexate W/Leucovorin CA Rescue VS Pentamidine In AIDS
    Trimetrexate W/Leucovorin CA Rescue VS Pentamidine In AIDSNational Center For Research Resources
    1992 - 1995
  • L-697,661 Compared To AZT In HIV Sero-Positive Patients
    L-697,661 Compared To AZT In HIV Sero-Positive PatientsNational Center For Research Resources
    1992 - 1995
  • Randomized Double-Blind Protocol In Acute Crytococcal Meningitis
    Randomized Double-Blind Protocol In Acute Crytococcal MeningitisNational Center For Research Resources
    1992 - 1995
  • SCH 39304 For Acute Cryptococal Meningitis In HIV Infected Patients
    SCH 39304 For Acute Cryptococal Meningitis In HIV Infected PatientsNational Center For Research Resources
    1992 - 1993
  • SCH 39304 To Patients With Advanced HIV Infection
    SCH 39304 To Patients With Advanced HIV InfectionNational Center For Research Resources
    1992 - 1995
  • Adult AIDS Clinical Trials Unit
    Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases
    1992 - 1999
  • Trimetrexate W/Leucovorin CA Rescue VS Trimethoprim/Sulfamethoxazole
    Trimetrexate W/Leucovorin CA Rescue VS Trimethoprim/SulfamethoxazoleNational Center For Research Resources
    1990 - 1990
  • Trimetrexate VS IV Pentamidine In AIDS Patients With PCP Refractory To T/S
    Trimetrexate VS IV Pentamidine In AIDS Patients With PCP Refractory To T/SNational Center For Research Resources
    1990 - 1990
  • Pharmacokinetic Study Of Single 600mg Oral Dose Of Sch39304
    Pharmacokinetic Study Of Single 600mg Oral Dose Of Sch39304National Center For Research Resources
    1990 - 1990
  • Maintenance Fluconazole And Amphotericin B For Crypto Meningitis In AIDS
    Maintenance Fluconazole And Amphotericin B For Crypto Meningitis In AIDSNational Center For Research Resources
    1990 - 1990

Hospital Affiliations

Insurance Accepted

  • Anthem PPO
  • BCBS Alabama PPO
  • BCBS Blue Card PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Healthfirst New York
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Physicians, view Dr. Saag's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV